about
In vitro non-viral gene delivery with nanofibrous scaffoldsRibonucleic acid interference induced gene knockdownRNA interference-based nanosystems for inflammatory bowel disease therapyMitigating the looming vaccine crisis: production and delivery of plasmid-based vaccinesCRISPR-Cas9 directed knock-out of a constitutively expressed gene using lance array nanoinjectionNon-viral gene delivery using nanoparticles.Therapeutic effects of long-circulating miR-135a-containing cationic immunoliposomes against gallbladder carcinoma.Development of a reduction-sensitive diselenide-conjugated oligoethylenimine nanoparticulate system as a gene carrier.Targeted delivery of siRNA into breast cancer cells via phage fusion proteins.The role of hydrophobic amino acid grafts in the enhancement of membrane-disruptive activity of pH-responsive pseudo-peptides.Stable gene transfection mediated by polysulfobetaine/PDMAEMA diblock copolymer in salted medium.3-D Scaffold Platform for Optimized Non-viral Transfection of Multipotent Stem Cells.Hyaluronic acid and fibrin hydrogels with concentrated DNA/PEI polyplexes for local gene delivery.Triolein-based polycation lipid nanocarrier for efficient gene delivery: characteristics and mechanism.Evaluating the intracellular stability and unpacking of DNA nanocomplexes by quantum dots-FRETImmune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor.Highly luminescent and cytocompatible cationic Ag2S NIR-emitting quantum dots for optical imaging and gene transfection.Self-assembly of DNA nanohydrogels with controllable size and stimuli-responsive property for targeted gene regulation therapy.Light-directed gene delivery by photochemical internalisation.Carrier-based strategies for targeting protein and peptide drugs to the lungs.Polymeric nanoparticles for gene delivery.Transfection efficiency of pORF lacZ plasmid lipopolyplex to hepatocytes and hepatoma cells.Cell-free 3D scaffold with two-stage delivery of miRNA-26a to regenerate critical-sized bone defects.Ethical perspectives on RNA interference therapeutics.Polycation-based nanoparticle delivery for improved RNA interference therapeutics.Mesoporous iron oxide nanoparticles prepared by polyacrylic acid etching and their application in gene delivery to mesenchymal stem cells.A family of bioreducible poly(disulfide amine)s for gene delivery.Gene transfer to hemophilia A mice via oral delivery of FVIII-chitosan nanoparticles.DNA release dynamics from bioreducible poly(amido amine) polyplexes.Oligopeptide-mediated gene transfer into mouse corneal endothelial cells: expression, design optimization, uptake mechanism and nuclear localization.Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities.Delivery of DNA vaccines: an overview on the use of biodegradable polymeric and magnetic nanoparticles.A sight on the current nanoparticle-based gene delivery vectors.Magnetic nanoparticles: Applications in gene delivery and gene therapy.The application of RNAi-based treatments for inflammatory bowel disease.DNA vaccination for prostate cancer: key concepts and considerations.Development of polymeric-cationic peptide composite nanoparticles, a nanoparticle-in-nanoparticle system for controlled gene delivery.Screening for Methylated Poly(l-histidine) with Various Dimethylimidazolium/Methylimidazole/Imidazole Contents as DNA Carrier.Chitosan nanoparticles as a potential nonviral gene delivery for HPV-16 E7 into mammalian cells.Degradable Polyethylenimine-Based Gene Carriers for Cancer Therapy.
P2860
Q24813608-98D44685-D4E0-4F83-9E12-D72A63999D87Q26829340-54F25BFB-5C51-4726-9469-09C5666D66E3Q28071518-1EF309F8-8A3C-4FC7-82BE-E5FA0858BB82Q28294355-B8055799-A222-411C-B409-B30C2BA8FE9CQ28830781-A3DA4FAF-ABE6-4E4A-B4E6-C533B4D65D93Q30381073-3EC2FEF8-BA22-4D36-9F4D-DBA6A15F0A7BQ33921112-FC68003E-7839-4BB3-B40E-FB5686C6D0A5Q34384071-A1C8192B-3BFE-4DF0-99B6-3EEDDBC643C7Q34501858-791F158D-C800-422E-B709-09B47ABB4D29Q34571080-FC356425-AD18-4AC6-B93F-42F98E769372Q34658781-F158C9AE-72DE-4DB9-81A0-6EF1C667EF06Q34755064-83ED044E-C340-49BA-9563-ECEFB4B4F558Q35112949-C756CE52-1EA9-4F13-988C-1DBB2E4ABBFCQ35547238-8357C6D9-D404-418B-90A3-B3EBC6AAEDEDQ35574622-0C301C39-BEDA-46CF-8F5F-9B928E2EB3FCQ35628183-90A6FA28-8AEC-4282-B661-C32B7BDC6EBBQ35661771-F486EFAC-E1B5-436C-B105-4F1BE806C173Q35665101-6C8094BB-1C9C-4711-A3C6-B186E15F8546Q35873756-261499AB-2D75-4233-86F2-F88E0B2D73EDQ36250762-FD0DA67A-D582-4C6C-83CF-A7A3B37462EAQ36460846-3188D9ED-BE2E-41BF-9441-06F35D113A6FQ36474300-291A02A7-1AAA-49F1-81C3-A8271BF335B3Q36527849-DE8952DC-A66B-4EAA-A34F-F71C30085AA6Q36743751-BE975774-D2C4-45DA-B333-A44F89AB413FQ37012046-687FE623-4ED9-4F38-A17E-8915E671B832Q37207251-C94BA6FE-D43D-430D-A8ED-12C7FA44ED3FQ37332356-15656FF9-4AFC-4003-82B7-6A3DC9D06C0AQ37368521-1C27E92D-5B68-4525-B44A-15F1FE93A85AQ37388713-BEE1BD96-F179-4045-B993-382611578291Q37393524-2AF9CA43-1847-4A6D-889B-0B501AA18917Q37626377-1B20451E-F313-4833-8D52-4916F7F34D54Q37730793-37C124C8-8087-467D-A8A7-4A4A91653934Q38220813-54D30D0B-675C-423E-815B-0718BB4CCE8EQ38366410-8EC29003-3664-43B2-BC55-8A4FC9A0C3C7Q38382964-772B0552-A24E-4D12-A922-95AC262B4F05Q38544772-39A6237D-E029-4FCA-9F89-1A2D0EFBAB51Q38813247-9236C66F-EE2D-4304-94F8-C1851FF736C8Q38840724-91A9076A-B4B0-4DFD-BA69-CBA0CE9499DEQ39014313-FDA17446-883E-43F2-A607-106CC333A647Q39177170-0F1CD39C-7A7D-4934-AD5B-5C347BDD2ED9
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Key issues in non-viral gene delivery.
@ast
Key issues in non-viral gene delivery.
@en
Key issues in non-viral gene delivery.
@nl
type
label
Key issues in non-viral gene delivery.
@ast
Key issues in non-viral gene delivery.
@en
Key issues in non-viral gene delivery.
@nl
prefLabel
Key issues in non-viral gene delivery.
@ast
Key issues in non-viral gene delivery.
@en
Key issues in non-viral gene delivery.
@nl
P1476
Key issues in non-viral gene delivery
@en
P2093
Seymour LW
P304
P356
10.1016/S0169-409X(00)00133-2
P407
P577
2001-03-01T00:00:00Z